STRATA CRITICAL MEDICAL, INC. Operating Expenses
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Operating Expenses of $20.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. operating expenses for the quarter ending 2026-06-30 was $20.62M, a 51.11% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. operating expenses for the quarter ending 2026-03-31 was $17.09M, a 34.17% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. operating expenses for the quarter ending 2025-06-30 was $13.65M.
- STRATA CRITICAL MEDICAL, INC. operating expenses for the quarter ending 2025-03-31 was $12.74M.
- STRATA CRITICAL MEDICAL, INC. operating expenses for fiscal 2025 was $63.48M, a 21.81% increase from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. operating expenses for fiscal 2024 was $52.11M.
- STRATA CRITICAL MEDICAL, INC. operating expenses for fiscal 2023 was -$33.23M.
- STRATA CRITICAL MEDICAL, INC. operating expenses for fiscal 2022 was -$36.57M.
| Period end | Operating Expenses 1 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 4 month | Operating Expenses 6 month | Operating Expenses 7 month | Operating Expenses 7 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $20.62M 10-Q · filed 2026-08-04 | $37.71M 10-Q · filed 2026-08-04 | |||||||
| 2026-03-31 | $17.09M 10-Q · filed 2026-05-06 | ||||||||
| 2025-12-31 | $63.48M 10-K · filed 2026-03-03 | ||||||||
| 2025-06-30 | $13.65M 10-Q · filed 2026-08-04 | $26.39M 10-Q · filed 2026-08-04 | |||||||
| 2025-03-31 | $12.74M 10-Q · filed 2026-05-06 | ||||||||
| 2024-12-31 | $52.11M 10-K · filed 2026-03-03 | ||||||||
| 2023-12-31 | -$7.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$16.00M derived: sum of 2 quarters · filed 2024-03-12 | -$23.88M derived: sum of 3 quarters · filed 2024-03-12 | -$33.23M 10-K · filed 2024-03-12 | |||||
| 2023-09-30 | -$8.16M 10-Q · filed 2023-11-08 | -$16.04M derived: sum of 2 quarters · filed 2023-11-08 | -$25.39M 10-Q · filed 2023-11-08 | -$34.15M derived: sum of 4 quarters · filed 2024-03-12 | |||||
| 2023-06-30 | -$7.88M 10-Q · filed 2023-08-09 | -$17.22M 10-Q · filed 2023-08-09 | -$25.98M derived: sum of 3 quarters · filed 2024-03-12 | -$36.99M derived: sum of 4 quarters · filed 2024-03-12 | |||||
| 2023-03-31 | -$9.35M 10-Q · filed 2023-05-11 | -$18.11M derived: sum of 2 quarters · filed 2024-03-12 | -$29.12M derived: sum of 3 quarters · filed 2024-03-12 | -$37.22M derived: sum of 4 quarters · filed 2024-03-12 | |||||
| 2022-12-31 | -$8.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$19.77M derived: sum of 2 quarters · filed 2024-03-12 | -$27.87M derived: sum of 3 quarters · filed 2024-03-12 | -$36.57M 10-K · filed 2024-03-12 | |||||
| 2022-09-30 | -$11.01M 10-Q · filed 2023-11-08 | -$19.11M derived: sum of 2 quarters · filed 2023-11-08 | -$27.81M 10-Q · filed 2023-11-08 | -$36.79M derived: sum of 4 quarters · filed 2023-11-08 | |||||
| 2022-06-30 | -$8.10M 10-Q · filed 2023-08-09 | -$16.80M 10-Q · filed 2023-08-09 | -$25.78M derived: sum of 3 quarters · filed 2023-08-09 | -$95.30M derived: sum of 4 quarters · filed 2023-08-09 | |||||
| 2022-03-31 | -$8.70M 10-Q · filed 2023-05-11 | -$17.68M derived: sum of 2 quarters · filed 2023-05-11 | -$87.19M derived: sum of 3 quarters · filed 2023-05-11 | -$66.47M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | -$8.98M 10-K · filed 2023-03-16 | -$78.50M derived: sum of 2 quarters · filed 2023-03-16 | -$57.78M derived: sum of 3 quarters · filed 2023-03-16 | -$57.54M derived: sum of 4 quarters · filed 2023-03-16 | |||||
| 2021-09-30 | -$69.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$48.80M derived: sum of 2 quarters · filed 2023-03-16 | -$48.56M derived: sum of 3 quarters · filed 2023-03-16 | -$24.94M 10-K · filed 2023-03-16 | |||||
| 2021-06-30 | $20.72M 10-Q · filed 2021-08-16 | $20.96M derived: sum of 2 quarters · filed 2021-08-16 | $44.57M 10-Q · filed 2021-08-16 | $21.37M derived: sum of 4 quarters · filed 2021-08-16 | |||||
| 2021-03-31 | $235.11K 10-Q · filed 2021-05-24 | $492.23K derived: sum of 2 quarters · filed 2021-05-24 | $652.91K derived: sum of 3 quarters · filed 2021-05-24 | $5.57M derived: sum of 4 quarters · filed 2021-08-16 | |||||
| 2020-12-31 | $257.11K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-07 | $417.80K derived: sum of 2 quarters · filed 2021-05-07 | $5.33M derived: sum of 3 quarters · filed 2021-08-16 | $678.49K 10-K/A · filed 2021-05-07 | |||||
| 2020-09-30 | $160.69K 10-Q · filed 2020-11-10 | $5.07M derived: sum of 2 quarters · filed 2021-08-16 | $421.37K 10-Q · filed 2020-11-10 | ||||||
| 2020-06-30 | $4.91M 10-Q · filed 2021-08-16 | $115.56K 10-Q · filed 2020-08-13 | $260.69K 10-Q · filed 2020-08-13 | $24.74M 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | $145.13K 10-Q · filed 2021-05-24 | ||||||||
| 2019-12-31 | $904.88K 10-K/A · filed 2021-05-07 | $268.21K 10-K · filed 2020-03-20 | |||||||
| 2019-09-30 | $43.05K 10-Q · filed 2020-11-10 | $44.05K 10-Q · filed 2020-11-10 | |||||||
| 2019-06-30 | $1.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |